On July 12, 2010
A Guide to the Competing Storylines at the FDA’s Hearing on Glaxo’s Diabetes Drug
An FDA advisory committee meets July 13 and 14 to decide the fate of GlaxoSmithKline’s Avandia, and the protagonists’ slideshows tell dramatically divergent stories about the diabetes drug. Although the decision ought to be made purely on the basis of
…
0 Comments